Opthalmology Drugs and Devices Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: O2D7B16A7982EN
Market Monitor Global

Abstracts

Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye.

This report contains market size and forecasts of Opthalmology Drugs and Devices in Global, including the following market information:

Global Opthalmology Drugs and Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Opthalmology Drugs and Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Opthalmology Drugs and Devices include Merck (US), Pfizer (US), Roche Holdings (Switzerland), Santen Pharmaceutical(Japan), Alcon (Switzerland), Bausch & Lomb (US), Carl Zeiss Meditec (Germany), Essilor International S.A. (France) and Johnson & Johnson (US), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opthalmology Drugs and Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Opthalmology Drugs and Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Opthalmology Drugs and Devices Market Segment Percentages, by Type, 2021 (%)

• Device
• Drug

Global Opthalmology Drugs and Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Opthalmology Drugs and Devices Market Segment Percentages, by Application, 2021 (%)

• Hosptial
• Clinic
• Others

Global Opthalmology Drugs and Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Opthalmology Drugs and Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Opthalmology Drugs and Devices revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Opthalmology Drugs and Devices revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck (US)
• Pfizer (US)
• Roche Holdings (Switzerland)
• Santen Pharmaceutical(Japan)
• Alcon (Switzerland)
• Bausch & Lomb (US)
• Carl Zeiss Meditec (Germany)
• Essilor International S.A. (France)
• Johnson & Johnson (US)
• Nidek(Japan)
• Topcon Corporation (Japan)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Opthalmology Drugs and Devices Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Opthalmology Drugs and Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OPTHALMOLOGY DRUGS AND DEVICES OVERALL MARKET SIZE

2.1 Global Opthalmology Drugs and Devices Market Size: 2021 VS 2028
2.2 Global Opthalmology Drugs and Devices Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Opthalmology Drugs and Devices Players in Global Market
3.2 Top Global Opthalmology Drugs and Devices Companies Ranked by Revenue
3.3 Global Opthalmology Drugs and Devices Revenue by Companies
3.4 Top 3 and Top 5 Opthalmology Drugs and Devices Companies in Global Market, by Revenue in 2021
3.5 Global Companies Opthalmology Drugs and Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opthalmology Drugs and Devices Players in Global Market
  3.6.1 List of Global Tier 1 Opthalmology Drugs and Devices Companies
  3.6.2 List of Global Tier 2 and Tier 3 Opthalmology Drugs and Devices Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Opthalmology Drugs and Devices Market Size Markets, 2021 & 2028
  4.1.2 Device
  4.1.3 Drug
4.2 By Type - Global Opthalmology Drugs and Devices Revenue & Forecasts
  4.2.1 By Type - Global Opthalmology Drugs and Devices Revenue, 2017-2022
  4.2.2 By Type - Global Opthalmology Drugs and Devices Revenue, 2023-2028
  4.2.3 By Type - Global Opthalmology Drugs and Devices Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Opthalmology Drugs and Devices Market Size, 2021 & 2028
  5.1.2 Hosptial
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Opthalmology Drugs and Devices Revenue & Forecasts
  5.2.1 By Application - Global Opthalmology Drugs and Devices Revenue, 2017-2022
  5.2.2 By Application - Global Opthalmology Drugs and Devices Revenue, 2023-2028
  5.2.3 By Application - Global Opthalmology Drugs and Devices Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Opthalmology Drugs and Devices Market Size, 2021 & 2028
6.2 By Region - Global Opthalmology Drugs and Devices Revenue & Forecasts
  6.2.1 By Region - Global Opthalmology Drugs and Devices Revenue, 2017-2022
  6.2.2 By Region - Global Opthalmology Drugs and Devices Revenue, 2023-2028
  6.2.3 By Region - Global Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Opthalmology Drugs and Devices Revenue, 2017-2028
  6.3.2 US Opthalmology Drugs and Devices Market Size, 2017-2028
  6.3.3 Canada Opthalmology Drugs and Devices Market Size, 2017-2028
  6.3.4 Mexico Opthalmology Drugs and Devices Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Opthalmology Drugs and Devices Revenue, 2017-2028
  6.4.2 Germany Opthalmology Drugs and Devices Market Size, 2017-2028
  6.4.3 France Opthalmology Drugs and Devices Market Size, 2017-2028
  6.4.4 U.K. Opthalmology Drugs and Devices Market Size, 2017-2028
  6.4.5 Italy Opthalmology Drugs and Devices Market Size, 2017-2028
  6.4.6 Russia Opthalmology Drugs and Devices Market Size, 2017-2028
  6.4.7 Nordic Countries Opthalmology Drugs and Devices Market Size, 2017-2028
  6.4.8 Benelux Opthalmology Drugs and Devices Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Opthalmology Drugs and Devices Revenue, 2017-2028
  6.5.2 China Opthalmology Drugs and Devices Market Size, 2017-2028
  6.5.3 Japan Opthalmology Drugs and Devices Market Size, 2017-2028
  6.5.4 South Korea Opthalmology Drugs and Devices Market Size, 2017-2028
  6.5.5 Southeast Asia Opthalmology Drugs and Devices Market Size, 2017-2028
  6.5.6 India Opthalmology Drugs and Devices Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Opthalmology Drugs and Devices Revenue, 2017-2028
  6.6.2 Brazil Opthalmology Drugs and Devices Market Size, 2017-2028
  6.6.3 Argentina Opthalmology Drugs and Devices Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Opthalmology Drugs and Devices Revenue, 2017-2028
  6.7.2 Turkey Opthalmology Drugs and Devices Market Size, 2017-2028
  6.7.3 Israel Opthalmology Drugs and Devices Market Size, 2017-2028
  6.7.4 Saudi Arabia Opthalmology Drugs and Devices Market Size, 2017-2028
  6.7.5 UAE Opthalmology Drugs and Devices Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck (US)
  7.1.1 Merck (US) Corporate Summary
  7.1.2 Merck (US) Business Overview
  7.1.3 Merck (US) Opthalmology Drugs and Devices Major Product Offerings
  7.1.4 Merck (US) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.1.5 Merck (US) Key News
7.2 Pfizer (US)
  7.2.1 Pfizer (US) Corporate Summary
  7.2.2 Pfizer (US) Business Overview
  7.2.3 Pfizer (US) Opthalmology Drugs and Devices Major Product Offerings
  7.2.4 Pfizer (US) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.2.5 Pfizer (US) Key News
7.3 Roche Holdings (Switzerland)
  7.3.1 Roche Holdings (Switzerland) Corporate Summary
  7.3.2 Roche Holdings (Switzerland) Business Overview
  7.3.3 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Major Product Offerings
  7.3.4 Roche Holdings (Switzerland) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.3.5 Roche Holdings (Switzerland) Key News
7.4 Santen Pharmaceutical(Japan)
  7.4.1 Santen Pharmaceutical(Japan) Corporate Summary
  7.4.2 Santen Pharmaceutical(Japan) Business Overview
  7.4.3 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Major Product Offerings
  7.4.4 Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.4.5 Santen Pharmaceutical(Japan) Key News
7.5 Alcon (Switzerland)
  7.5.1 Alcon (Switzerland) Corporate Summary
  7.5.2 Alcon (Switzerland) Business Overview
  7.5.3 Alcon (Switzerland) Opthalmology Drugs and Devices Major Product Offerings
  7.5.4 Alcon (Switzerland) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.5.5 Alcon (Switzerland) Key News
7.6 Bausch & Lomb (US)
  7.6.1 Bausch & Lomb (US) Corporate Summary
  7.6.2 Bausch & Lomb (US) Business Overview
  7.6.3 Bausch & Lomb (US) Opthalmology Drugs and Devices Major Product Offerings
  7.6.4 Bausch & Lomb (US) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.6.5 Bausch & Lomb (US) Key News
7.7 Carl Zeiss Meditec (Germany)
  7.7.1 Carl Zeiss Meditec (Germany) Corporate Summary
  7.7.2 Carl Zeiss Meditec (Germany) Business Overview
  7.7.3 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Major Product Offerings
  7.7.4 Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.7.5 Carl Zeiss Meditec (Germany) Key News
7.8 Essilor International S.A. (France)
  7.8.1 Essilor International S.A. (France) Corporate Summary
  7.8.2 Essilor International S.A. (France) Business Overview
  7.8.3 Essilor International S.A. (France) Opthalmology Drugs and Devices Major Product Offerings
  7.8.4 Essilor International S.A. (France) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.8.5 Essilor International S.A. (France) Key News
7.9 Johnson & Johnson (US)
  7.9.1 Johnson & Johnson (US) Corporate Summary
  7.9.2 Johnson & Johnson (US) Business Overview
  7.9.3 Johnson & Johnson (US) Opthalmology Drugs and Devices Major Product Offerings
  7.9.4 Johnson & Johnson (US) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.9.5 Johnson & Johnson (US) Key News
7.10 Nidek(Japan)
  7.10.1 Nidek(Japan) Corporate Summary
  7.10.2 Nidek(Japan) Business Overview
  7.10.3 Nidek(Japan) Opthalmology Drugs and Devices Major Product Offerings
  7.10.4 Nidek(Japan) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.10.5 Nidek(Japan) Key News
7.11 Topcon Corporation (Japan)
  7.11.1 Topcon Corporation (Japan) Corporate Summary
  7.11.2 Topcon Corporation (Japan) Business Overview
  7.11.3 Topcon Corporation (Japan) Opthalmology Drugs and Devices Major Product Offerings
  7.11.4 Topcon Corporation (Japan) Opthalmology Drugs and Devices Revenue in Global Market (2017-2022)
  7.11.5 Topcon Corporation (Japan) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Opthalmology Drugs and Devices Market Opportunities & Trends in Global Market
Table 2. Opthalmology Drugs and Devices Market Drivers in Global Market
Table 3. Opthalmology Drugs and Devices Market Restraints in Global Market
Table 4. Key Players of Opthalmology Drugs and Devices in Global Market
Table 5. Top Opthalmology Drugs and Devices Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Opthalmology Drugs and Devices Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Opthalmology Drugs and Devices Revenue Share by Companies, 2017-2022
Table 8. Global Companies Opthalmology Drugs and Devices Product Type
Table 9. List of Global Tier 1 Opthalmology Drugs and Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opthalmology Drugs and Devices Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opthalmology Drugs and Devices Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Opthalmology Drugs and Devices Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Opthalmology Drugs and Devices Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Opthalmology Drugs and Devices Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Opthalmology Drugs and Devices Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Opthalmology Drugs and Devices Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Opthalmology Drugs and Devices Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Opthalmology Drugs and Devices Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Opthalmology Drugs and Devices Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Opthalmology Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Opthalmology Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Opthalmology Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Opthalmology Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Opthalmology Drugs and Devices Revenue, (US$, Mn), 2023-2028
Table 30. Merck (US) Corporate Summary
Table 31. Merck (US) Opthalmology Drugs and Devices Product Offerings
Table 32. Merck (US) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer (US) Corporate Summary
Table 34. Pfizer (US) Opthalmology Drugs and Devices Product Offerings
Table 35. Pfizer (US) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 36. Roche Holdings (Switzerland) Corporate Summary
Table 37. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Product Offerings
Table 38. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 39. Santen Pharmaceutical(Japan) Corporate Summary
Table 40. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Product Offerings
Table 41. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 42. Alcon (Switzerland) Corporate Summary
Table 43. Alcon (Switzerland) Opthalmology Drugs and Devices Product Offerings
Table 44. Alcon (Switzerland) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 45. Bausch & Lomb (US) Corporate Summary
Table 46. Bausch & Lomb (US) Opthalmology Drugs and Devices Product Offerings
Table 47. Bausch & Lomb (US) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 48. Carl Zeiss Meditec (Germany) Corporate Summary
Table 49. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Product Offerings
Table 50. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 51. Essilor International S.A. (France) Corporate Summary
Table 52. Essilor International S.A. (France) Opthalmology Drugs and Devices Product Offerings
Table 53. Essilor International S.A. (France) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 54. Johnson & Johnson (US) Corporate Summary
Table 55. Johnson & Johnson (US) Opthalmology Drugs and Devices Product Offerings
Table 56. Johnson & Johnson (US) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 57. Nidek(Japan) Corporate Summary
Table 58. Nidek(Japan) Opthalmology Drugs and Devices Product Offerings
Table 59. Nidek(Japan) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)
Table 60. Topcon Corporation (Japan) Corporate Summary
Table 61. Topcon Corporation (Japan) Opthalmology Drugs and Devices Product Offerings
Table 62. Topcon Corporation (Japan) Opthalmology Drugs and Devices Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Opthalmology Drugs and Devices Segment by Type in 2021
Figure 2. Opthalmology Drugs and Devices Segment by Application in 2021
Figure 3. Global Opthalmology Drugs and Devices Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opthalmology Drugs and Devices Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opthalmology Drugs and Devices Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opthalmology Drugs and Devices Revenue in 2021
Figure 8. By Type - Global Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 9. By Application - Global Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 10. By Region - Global Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 11. By Country - North America Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 12. US Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 16. Germany Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 17. France Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 24. China Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 28. India Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 30. Brazil Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Opthalmology Drugs and Devices Revenue Market Share, 2017-2028
Figure 33. Turkey Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Opthalmology Drugs and Devices Revenue, (US$, Mn), 2017-2028
Figure 37. Merck (US) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer (US) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Holdings (Switzerland) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Santen Pharmaceutical(Japan) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alcon (Switzerland) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch & Lomb (US) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Carl Zeiss Meditec (Germany) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Essilor International S.A. (France) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson & Johnson (US) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nidek(Japan) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Topcon Corporation (Japan) Opthalmology Drugs and Devices Revenue Year Over Year Growth (US$, Mn) & (2017-2022)